Tebubio

Tebubio

Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $13.8M

Overview

Tebubio is a Paris-based life science tools and services company that accelerates biomedical research by providing high-value reagents and integrated contract research services. Its business model combines e-commerce distribution of cutting-edge research tools from partner innovators with a client-focused, project management-driven service platform. The company focuses on high-growth areas like cell therapy, advanced cell culture, gene expression, and live-cell imaging, positioning itself as a solutions partner rather than just a supplier.

DiagnosticsAntibodies

Technology Platform

Integrated platform combining curated e-commerce distribution of third-party life science research tools with PhD-managed contract research services.

Funding History

2
Total raised:$13.8M
Series A$12M
Seed$1.8M

Opportunities

Capitalizing on the growing demand for specialized tools in cell/gene therapy and complex cell culture, and the trend towards outsourcing niche research tasks to expert CROs.
Expansion of its service model geographically and into new application areas presents significant growth potential.

Risk Factors

High dependency on third-party suppliers for its product portfolio risks disruption.
Intense competition from large global distributors and scalability challenges in its high-touch service model could limit growth and margins.

Competitive Landscape

Operates in a fragmented but competitive space, competing against large, broad-line distributors (e.g., Thermo Fisher) and numerous niche specialists. Differentiates through deep technical curation, integrated services, and a strong focus on customer partnership via PhD-level project management.